Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Neuwirtová

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Casopis Lekaru Ceskych|September 25, 2001
[Will knowledge of the mechanisms of apoptosis lead to new therapeutic procedures?]R Neuwirtová
Vnitrni Lekarstvi|January 1, 1992
[Cytosine arabinoside in low doses in the treatment of myelodysplastic syndrome. Czechoslovak MDS Cooperative Group]R Neuwirtová
Vnitrni Lekarstvi|June 8, 2006
[Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB]O Fuchs, R Neuwirtová
Vnitrni Lekarstvi|July 29, 2006
[Ubiquitins, proteasomes, sumoylation and application today and in future for cancer and other diseases therapy II. Sumoylation and neddylation as posttranslational modifications of proteins and their ubiquitinylation and its significance]O Fuchs, R Neuwirtová
Casopis Lekaru Ceskych|June 24, 1992
[Growth factors in hematology]J Kvasnicka, R Neuwirtová
Blut|November 1, 1990
Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritinsV Cukrová, R Neuwirtová
Casopis Lekaru Ceskych|September 28, 1998
[Use of cyclosporin A in hematology]A Jonásová, R Neuwirtová
Zeitschrift Fur Alternsforschung|September 1, 1987
Serum ferritin in institutionalised elderly patientsE Topinková, R Neuwirtová
Casopis Lekaru Ceskych|December 6, 2003
[The comet assay: principles of the method and clinical utilization]B Novotná, R Neuwirtová, V Blazková, et al.
Neoplasma|January 1, 1980
The blood volume and splenic red cell pool in hairy cell leukemiaB Friedmann, F Hermanský, Z Voslárová, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Casopis Lekaru Ceskych|September 25, 2001
[Will knowledge of the mechanisms of apoptosis lead to new therapeutic procedures?]R Neuwirtová
Vnitrni Lekarstvi|January 1, 1992
[Cytosine arabinoside in low doses in the treatment of myelodysplastic syndrome. Czechoslovak MDS Cooperative Group]R Neuwirtová
Vnitrni Lekarstvi|June 8, 2006
[Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB]O Fuchs, R Neuwirtová
Vnitrni Lekarstvi|July 29, 2006
[Ubiquitins, proteasomes, sumoylation and application today and in future for cancer and other diseases therapy II. Sumoylation and neddylation as posttranslational modifications of proteins and their ubiquitinylation and its significance]O Fuchs, R Neuwirtová
Casopis Lekaru Ceskych|June 24, 1992
[Growth factors in hematology]J Kvasnicka, R Neuwirtová
Blut|November 1, 1990
Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritinsV Cukrová, R Neuwirtová
Casopis Lekaru Ceskych|September 28, 1998
[Use of cyclosporin A in hematology]A Jonásová, R Neuwirtová
Zeitschrift Fur Alternsforschung|September 1, 1987
Serum ferritin in institutionalised elderly patientsE Topinková, R Neuwirtová
Casopis Lekaru Ceskych|December 6, 2003
[The comet assay: principles of the method and clinical utilization]B Novotná, R Neuwirtová, V Blazková, et al.
Neoplasma|January 1, 1980
The blood volume and splenic red cell pool in hairy cell leukemiaB Friedmann, F Hermanský, Z Voslárová, et al.
Pageof 4